1Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
2Department of Radiology, Abdominal Imaging Division, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
3Department of Pathology, Anatomy, & Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
4Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
5Liver Disease prevention Center, Division of Gastroenterology and Hepatology Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Correspondence Address: Dr. Hie-Won Hann, FAASLD, Professor of Medicine, Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. E-mail: hie-won.hann@jefferson.edu
Revised: 24 Jun 2019 | Accepted: 24 Jun 2019 | Published: 28 Jun 2019
The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction:
Conflict of Interest:
Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences.
Ralph Zinner: Bristol Myers Squibb, Merck
Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest.
We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.
Block PD, Shinn BJ, Roth CG, Baliff JP, Zinner RG, Hann HW. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma Res 2019;5:22. http://dx.doi.org/10.20517/2394-5079.2019.017
AMA Style
Block PD, Shinn BJ, Roth CG, Baliff JP, Zinner RG, Hann HW. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma Research. 2019; 5: 22. http://dx.doi.org/10.20517/2394-5079.2019.017
Chicago/Turabian Style
Block, Peter D., Brianna J. Shinn, Christopher G. Roth, Jeffrey P. Baliff, Ralph G. Zinner, Hie-Won Hann. 2019. "Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B" Hepatoma Research. 5: 22. http://dx.doi.org/10.20517/2394-5079.2019.017
ACS Style
Block, PD.; Shinn BJ.; Roth CG.; Baliff JP.; Zinner RG.; Hann H.W. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma. Res.2019, 5, 22. http://dx.doi.org/10.20517/2394-5079.2019.017
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any
comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any
queries or need any help, please contact us at
support@oaepublish.com.
0
Cite This Article 1 clicks
Like This Article 0
likes
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.